Your browser is no longer supported. Please, upgrade your browser.
Settings
ILMN Illumina, Inc. daily Stock Chart
ILMN [NASD]
Illumina, Inc.
IndexS&P 500 P/E53.37 EPS (ttm)3.13 Insider Own0.70% Shs Outstand147.22M Perf Week2.11%
Market Cap24.56B Forward P/E38.86 EPS next Y4.29 Insider Trans-2.46% Shs Float144.73M Perf Month4.18%
Income462.60M PEG4.65 EPS next Q0.64 Inst Own94.90% Short Float3.92% Perf Quarter24.09%
Sales2.40B P/S10.24 EPS this Y0.90% Inst Trans-1.47% Short Ratio4.51 Perf Half Y-1.57%
Book/sh14.97 P/B11.14 EPS next Y18.13% ROA11.40% Target Price156.11 Perf Year7.41%
Cash/sh10.59 P/C15.76 EPS next 5Y11.47% ROE21.80% 52W Range119.37 - 186.88 Perf YTD30.29%
Dividend- P/FCF59.07 EPS past 5Y38.00% ROI14.00% 52W High-10.73% Beta0.80
Dividend %- Quick Ratio2.90 Sales past 5Y17.80% Gross Margin69.50% 52W Low39.75% ATR3.08
Employees5500 Current Ratio3.30 Sales Q/Q4.70% Oper. Margin24.50% RSI (14)69.70 Volatility2.04% 1.90%
OptionableYes Debt/Eq0.48 EPS Q/Q19.20% Profit Margin19.30% Rel Volume1.23 Prev Close160.00
ShortableYes LT Debt/Eq0.48 EarningsJan 31 AMC Payout0.00% Avg Volume1.26M Price166.82
Recom2.70 SMA202.87% SMA5010.71% SMA20010.51% Volume1,550,439 Change4.26%
Feb-01-17Reiterated UBS Buy $180 → $185
Jan-18-17Initiated Deutsche Bank Hold $160
Jan-10-17Upgrade BofA/Merrill Neutral → Buy
Jan-06-17Upgrade CL King Neutral → Buy
Dec-07-16Reiterated Morgan Stanley Underweight $115 → $100
Nov-10-16Resumed Leerink Partners Mkt Perform
Nov-02-16Downgrade First Analysis Sec Equal-Weight → Underweight $130 → $116
Oct-11-16Reiterated Cantor Fitzgerald Hold $165 → $155
Oct-11-16Reiterated Canaccord Genuity Hold $165 → $136
Oct-11-16Downgrade Citigroup Buy → Neutral
Aug-22-16Downgrade CL King Buy → Neutral
Jul-27-16Reiterated Mizuho Neutral $138 → $148
Jul-05-16Downgrade Morgan Stanley Equal-Weight → Underweight $130 → $110
Jun-22-16Initiated CL King Buy
May-04-16Reiterated Stifel Buy $215 → $160
May-04-16Reiterated Mizuho Neutral $150 → $138
May-04-16Reiterated Canaccord Genuity Hold $160 → $140
May-03-16Reiterated UBS Buy $210 → $180
May-03-16Reiterated Morgan Stanley Overweight $140 → $130
Apr-19-16Downgrade Cantor Fitzgerald Buy → Hold
Feb-27-17 05:08PM  The Hot Stock: Illumina Jumps 4.3% at Barrons.com
04:35PM  [$$] Medical Megadeals Dominate Deal Flow at The Wall Street Journal
Feb-24-17 10:00AM  4 Stocks You Can Buy and Hold Forever at Motley Fool
Feb-21-17 01:21PM  ILLUMINA INC Files SEC form 8-K, Change in Directors or Principal Officers
11:57AM  Baron Opportunity Fund Comments on Illumina
06:30AM  Illumina to Webcast Live Presentation at the Cowen and Company Annual Health Care Conference Business Wire
Feb-20-17 09:00AM  Illumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to Illumina Business Wire
Feb-18-17 08:45AM  Why Illumina Is a Buy at Motley Fool
Feb-17-17 11:27PM  Top Stocks Poised to Bounce Back in 2017 at Motley Fool
01:04PM  ILLUMINA INC Financials
Feb-15-17 08:20AM  3 Stocks Set to Profit From the Rise of China at Motley Fool
Feb-14-17 07:29AM  What Illumina's New Products Mean for 2017 and Beyond at Motley Fool
06:10AM  ILLUMINA INC Files SEC form 10-K, Annual Report
03:59AM  Better Buy: Illumina or Gilead Sciences? at Motley Fool
Feb-13-17 08:03PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses Exceeding $250,000 to Contact the Firm Accesswire
02:12PM  DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Illumina, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017 ILMN GlobeNewswire
12:43PM  Baron Funds' Fifth Avenue Growth Fund Comments on Illumina
12:30PM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses Exceeding $250,000 to Contact the Firm Accesswire
12:29PM  Baron Funds' Baron Fifth Avenue Growth Fund 4th Quarter Commentary
10:39AM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Illumina Inc. (ILMN) & Lead Plaintiff Deadline: February 14, 2017 GlobeNewswire
08:33AM  ILLUMINA INC Files SEC form 8-K, Other Events
Feb-08-17 04:53PM  Better Buy: Illumina, Inc. vs. Thermo Fisher Scientific at Motley Fool
04:32PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
01:20PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Illumina, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017 ILMN Business Wire
Feb-07-17 02:22PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Illumina, Inc. - ILMN PR Newswire
12:40PM  IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:40AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Illumina Inc. (ILMN) and Lead Plaintiff Deadline: February 14, 2017 Accesswire
Feb-06-17 04:21PM  Why Illumina, Inc. Soared 25% in January at Motley Fool
11:36AM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
09:31AM  Could President Trump's Policies Be Terrible for These Healthcare Stocks? at Motley Fool
07:16AM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Illumina, Inc. to Contact the Firm Before Imminent Lead Plaintiff Deadline Accesswire
Feb-04-17 07:22AM  5 Best Stocks for High-Risk Investors at Motley Fool
Feb-03-17 08:51PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
08:05PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Illumina, Inc. of Class Action Lawsuit and Upcoming Deadline - ILMN Accesswire
12:54PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:39AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Illumina Inc. (ILMN) and Lead Plaintiff Deadline: February 14, 2017 Accesswire
10:04AM  ILMN SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Illumina, Inc. and a Lead Plaintiff Deadline of February 14, 2017 Business Wire
Feb-02-17 10:43AM  Illumina, Inc. :ILMN-US: Earnings Analysis: 2016 By the Numbers : February 2, 2017
09:21AM  Illumina, Inc. :ILMN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 2, 2017
06:51AM  [$$] Illumina, Up 26% So Far This Year, Can Stay Hot at Barrons.com
06:45AM  5 Things Illumina's Management Wants You to Know at Motley Fool
Feb-01-17 03:43PM  Illumina Q4 Results Beat the Street at Investopedia
12:30PM  Pacific Biosciences: A Small Cap Gem in the Genomics Market at Motley Fool
12:06PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:30AM  Investor Alert: GPM Reminds Investors of the February 14 Deadline in the Class Action Lawsuit Against Illumina, Inc. Business Wire
08:14AM  Top Healthcare Stocks to Buy in 2017 at Motley Fool
08:04AM  5 Growth Stocks to Buy in February at Motley Fool
08:01AM  Illumina (ILMN) Beats Q4 Earnings & Revenues, Guides 2017
Jan-31-17 10:08PM  Edited Transcript of ILMN earnings conference call or presentation 31-Jan-17 10:00pm GMT
06:44PM  Illumina Inc. Ends 2016 on a Strong Note Thanks to Consumables Sales at Motley Fool
05:00PM  Illumina Inc Earnings Call scheduled for 5:00 pm ET today
04:48PM  Illumina beats Street 4Q forecasts
04:29PM  Illumina Reports Full Financial Results for Fourth Quarter and Fiscal Year 2016 Business Wire
09:14AM  Growth Investing 2017: 3 Stocks to Put on Your Radar at Motley Fool
08:33AM  13 Questions For Bryan Roberts Of Venrock at Forbes
07:07AM  Q4 2016 Illumina Inc Earnings Release - After Market Close
Jan-30-17 06:41PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
03:08PM  ILMN INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Illumina, Inc. and a Lead Plaintiff Deadline of February 14, 2017 PR Newswire
03:07PM  Baron Asset Fund Comments on Illumina Inc.
02:54PM  Baron Asset Fund 4th Quarter Shareholder Letter
10:54AM  CRUCIAL SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:13AM  This Could Be January's Best Stock at Motley Fool
08:42AM  Why Illumina (ILMN) Might Surprise This Earnings Season
03:00AM  Illumina Debuts VeriSeq Analysis Software (48 Samples), Optimized Data Analysis for Noninvasive Prenatal Testing Business Wire
Jan-29-17 11:43AM  3 Things You'll Want to Watch in Illumina's Q4 Earnings at Motley Fool
Jan-28-17 02:00PM  Johnson & Weaver, LLP Announces Investigations of The Southern Company, Illumina, Inc., PixarBio Corporation and Midcoast Energy Partners, L.P. PR Newswire
Jan-27-17 11:53PM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Illumina, Inc. of Class Action Lawsuit and Upcoming Deadline - ILMN Accesswire
04:36PM  ILLUMINA INC Files SEC form 8-K, Change in Directors or Principal Officers
09:00AM  Illumina Names Caroline Dorsa to Its Board of Directors, Adding Over 30 Years of Leadership Experience in the Healthcare, Telecommunications and Energy Industries Business Wire
Jan-26-17 04:28PM  What to Expect When Illumina Reports Earnings at Motley Fool
11:28AM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:30AM  February 14 Deadline Alert: Law Offices of Howard G. Smith Reminds Illumina, Inc. Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm Business Wire
09:13AM  Why Investors Are Paying a Premium for Ilumina, Inc. at Motley Fool
Jan-25-17 05:14PM  Even After Price Jump, Vetr Upgrades Illumina
01:43PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
01:10PM  Dow 20,000: 3 Healthcare Stocks You Can Still Buy at Motley Fool
11:05AM  Illumina Gains from Roche-Pacific Biosciences Deal Termination at Investopedia
10:39AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Illumina Inc. (ILMN) and Lead Plaintiff Deadline - February 14, 2017 Accesswire
Jan-24-17 09:16PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
08:36PM  ILMN LOSS ALERT: Rosen Law Firm Reminds Illumina, Inc. Investors of Important Deadline in Class Action ILMN GlobeNewswire
04:01PM  CareDx to acquire SBT Resolver HLA Typing Products from Illumina GlobeNewswire
Jan-23-17 04:28PM  What's Ahead for Healthcare in 2017? at Motley Fool
12:30PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
11:07AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017 Business Wire
Jan-22-17 07:27AM  3 Healthcare Stocks You'll Want to Watch in the First Quarter at Motley Fool
07:21AM  After Disappointing Investors Last Year, These Stocks Could Surge in 2017 at Motley Fool
Jan-20-17 09:14PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Illumina, Inc. of Class Action Lawsuit and Upcoming Deadline - ILMN PR Newswire
Jan-19-17 12:28PM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
11:56AM  ILMN SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Illumina, Inc. and a Lead Plaintiff Deadline of February 14, 2017 Business Wire
09:57AM  Did Roche Just Hand Illumina Pacific Biosciences Head on a Platter? at Motley Fool
Jan-18-17 03:56PM  Coverage initiated on Illumina by Deutsche Bank
12:29PM  Deutsche Bank Optimistic On Fundamentals In Life Science Tools/Diagnostics Sector
07:31AM  Illumina (ILMN) Q4 Earnings: A Beat in Store for the Stock?
Jan-17-17 04:20PM  5 Healthcare Stocks Poised for Maximum Gains in 2017 at Motley Fool
06:30AM  Illumina to Announce Fourth Quarter and Fiscal Year 2016 Financial Results on Tuesday, January 31, 2017 Business Wire
06:00AM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Jan-16-17 10:38AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Illumina Inc. (ILMN) and Lead Plaintiff Deadline: February 14, 2017 Accesswire
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company's sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array. In addition, the company provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and non-invasive prenatal testing services. It serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as through life-science distributors. It has collaboration agreements with IBM Watson Health to access genome data interpretation by integrating Watson for genomics into Illumina's BaseSpace Sequence Hub and tumor sequencing process; and NRGene to develop new molecular breeding tools for cattle to support global food production. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRADBURY DANIELDirectorFeb 17Option Exercise71.0960042,65417,065Feb 21 09:05 PM
BRADBURY DANIELDirectorFeb 17Sale162.8060097,67716,465Feb 21 09:05 PM
OSTADAN OMEADEVP Ops, Products, StrategyFeb 15Option Exercise0.008,438033,009Feb 17 08:16 PM
Dadswell CharlesSr VP & General CounselFeb 15Option Exercise0.007,032014,699Feb 17 08:22 PM
FLATLEY JAY TDirectorFeb 15Option Exercise0.0028,5100527,236Feb 17 08:37 PM
Ronaghi MostafaSr VP & CTOFeb 15Option Exercise0.007,032067,922Feb 17 08:45 PM
Stapley MarcEVP & Chief Administrative OfcFeb 15Option Exercise0.008,438044,423Feb 17 08:51 PM
deSouza Francis APresident and CEOFeb 15Option Exercise0.0014,318082,523Feb 17 09:05 PM
Bouchard MichelChief Accounting OfficerFeb 15Option Exercise0.002,625025,292Feb 17 08:11 PM
OSTADAN OMEADEVP Ops, Products, StrategyFeb 13Sale163.102,173354,41624,571Feb 15 07:42 PM
BOWMAN A BLAINEDirectorFeb 08Option Exercise70.193,000210,56018,704Feb 10 03:55 PM
BOWMAN A BLAINEDirectorFeb 08Sale162.743,000488,23115,704Feb 10 03:55 PM
Dadswell CharlesSr VP & General CounselFeb 06Sale161.2657292,2417,592Feb 08 07:39 PM
OSTADAN OMEADEVP Ops, Products, StrategyFeb 02Sale160.411,104177,09326,586Feb 06 08:17 PM
OSTADAN OMEADEVP Ops, Products, StrategyJan 30Sale160.9025941,67327,690Jan 31 07:31 PM
OSTADAN OMEADEVP Ops, Products, StrategyJan 19Sale160.3537860,61228,662Jan 19 05:56 PM
OSTADAN OMEADEVP Ops, Products, StrategyJan 17Sale160.002,000320,00029,040Jan 19 05:56 PM
BOWMAN A BLAINEDirectorJan 11Option Exercise42.823,000128,46018,704Jan 13 07:05 PM
BOWMAN A BLAINEDirectorJan 11Sale162.893,000488,65815,704Jan 13 07:05 PM
Dadswell CharlesSr VP & General CounselJan 10Sale161.6011618,7468,420Jan 12 09:36 PM
BRADBURY DANIELDirectorJan 04Option Exercise71.0960042,65417,065Jan 06 06:59 PM
BRADBURY DANIELDirectorJan 04Sale135.0160081,00816,465Jan 06 06:59 PM
OSTADAN OMEADEVP Ops, Products, StrategyDec 15Sale126.162,000252,32031,040Dec 19 08:08 PM
BRADBURY DANIELDirectorDec 12Option Exercise71.0960042,65417,065Dec 14 08:09 PM
BRADBURY DANIELDirectorDec 12Sale123.4260074,05416,465Dec 14 08:09 PM
OSTADAN OMEADEVP Ops, Products, StrategyDec 08Sale121.633,000364,89052,988Dec 09 04:18 PM
OSTADAN OMEADEVP Ops, Products, StrategyDec 01Sale133.303,000399,90051,492Dec 05 06:41 PM
BRADBURY DANIELDirectorNov 14Option Exercise71.0960042,65417,065Nov 15 06:14 PM
BRADBURY DANIELDirectorNov 14Sale136.3460081,80316,465Nov 15 06:14 PM
BRADBURY DANIELDirectorOct 07Option Exercise71.0960042,65417,065Oct 11 08:35 PM
BRADBURY DANIELDirectorOct 07Sale184.36600110,61316,465Oct 11 08:35 PM
Dadswell CharlesSr VP & General CounselOct 04Sale182.3811621,15639,900Oct 06 05:32 PM
EPSTEIN ROBERT SDirectorSep 20Sale174.2930052,2876,924Sep 21 06:56 PM
Stapley MarcEVP & Chief Administrative OfcSep 15Sale172.871,270219,54332,746Sep 16 08:07 PM
BRADBURY DANIELDirectorSep 14Option Exercise71.0960042,65417,065Sep 16 07:58 PM
BRADBURY DANIELDirectorSep 14Sale171.25600102,74816,465Sep 16 07:58 PM
Dadswell CharlesSr VP & General CounselSep 06Sale168.0111619,48940,016Sep 08 07:58 PM
FLATLEY JAY TDirectorAug 23Option Exercise36.3020,000726,000508,061Aug 25 08:43 PM
FLATLEY JAY TDirectorAug 23Sale172.9920,0003,459,877488,061Aug 25 08:43 PM
EPSTEIN ROBERT SDirectorAug 22Sale170.2730051,0817,224Aug 24 07:52 PM
EPSTEIN ROBERT SDirectorAug 22Sale170.2730051,0817,224Aug 23 08:19 PM
BRADBURY DANIELDirectorAug 17Option Exercise71.0960042,65417,065Aug 18 08:31 PM
BRADBURY DANIELDirectorAug 17Sale168.42600101,05316,465Aug 18 08:31 PM
FLATLEY JAY TDirectorAug 15Option Exercise36.3010,000363,000498,061Aug 16 06:56 PM
FLATLEY JAY TDirectorAug 15Sale170.0010,0001,700,000488,061Aug 16 06:56 PM
WHITFIELD ROY ADirectorAug 12Option Exercise42.824,000171,2806,853Aug 15 06:03 PM
WHITFIELD ROY ADirectorAug 12Sale167.224,000668,8802,853Aug 15 06:03 PM
FLATLEY JAY TDirectorAug 09Option Exercise36.3010,000363,000498,061Aug 10 09:40 PM
FLATLEY JAY TDirectorAug 09Sale165.9710,0001,659,650488,061Aug 10 09:40 PM
Dadswell CharlesSr VP & General CounselAug 04Sale164.6311619,09740,132Aug 08 06:36 PM
FLATLEY JAY TDirectorAug 01Option Exercise36.3010,000363,000498,061Aug 02 07:27 PM
FLATLEY JAY TDirectorAug 01Sale170.0010,0001,700,000488,061Aug 02 07:27 PM
Dadswell CharlesSr VP & General CounselJul 27Sale155.008,6321,337,96040,248Jul 28 07:44 PM
FLATLEY JAY TDirectorJul 26Option Exercise36.3010,000363,000498,061Jul 28 07:39 PM
FLATLEY JAY TDirectorJul 26Sale150.0010,0001,500,000488,061Jul 28 07:39 PM
EPSTEIN ROBERT SDirectorJul 20Sale150.0030045,0007,524Jul 20 08:08 PM
FLATLEY JAY TDirectorJul 18Option Exercise36.3010,000363,000498,061Jul 20 08:06 PM
EPSTEIN ROBERT SDirectorJul 18Sale150.00900135,0007,824Jul 20 08:08 PM
FLATLEY JAY TDirectorJul 18Sale150.0010,0001,500,010488,061Jul 20 08:06 PM
BOWMAN A BLAINEDirectorJul 14Option Exercise42.825,000214,10020,704Jul 15 06:53 PM
BOWMAN A BLAINEDirectorJul 14Sale147.145,000735,70515,704Jul 15 06:53 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerJul 11Sale141.89716101,59318,976Jul 12 07:47 PM
BOWMAN A BLAINEDirectorJun 16Option Exercise42.825,000214,10020,704Jun 17 07:53 PM
BOWMAN A BLAINEDirectorJun 16Sale135.085,000675,38815,704Jun 17 07:53 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerJun 15Sale137.902,141295,24219,692Jun 15 06:47 PM
WHITFIELD ROY ADirectorJun 13Option Exercise42.822,00085,6406,653Jun 15 06:34 PM
WHITFIELD ROY ADirectorJun 13Sale140.443,800533,6722,853Jun 15 06:34 PM
EASTHAM KARINDirectorJun 01Option Exercise36.295,000181,45017,424Jun 03 07:28 PM
EASTHAM KARINDirectorJun 01Sale145.355,000726,75012,424Jun 03 07:28 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerMay 25Sale144.732,141309,86721,833May 26 07:44 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerMay 17Sale140.842,141301,53223,974May 19 06:56 PM
BOWMAN A BLAINEDirectorMay 12Option Exercise36.295,000181,45018,615May 13 06:03 PM
BOWMAN A BLAINEDirectorMay 12Sale137.115,000685,53513,615May 13 06:03 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerApr 27Sale138.462,141296,44626,115Apr 28 06:34 PM
Bianchi Paul LSr. VP, Human ResourcesApr 18Sale175.001,884329,70065,660Apr 20 05:33 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerApr 18Sale176.012,141376,83528,256Apr 20 05:57 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerApr 13Option Exercise37.0412,500463,00042,897Apr 14 06:43 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerApr 13Sale175.0012,5002,187,50030,397Apr 14 06:43 PM
WHITFIELD ROY ADirectorApr 12Option Exercise42.824,000171,2805,800Apr 14 06:21 PM
FLATLEY JAY TChief Executive OfficerApr 12Option Exercise36.3020,000726,000508,061Apr 14 06:42 PM
FLATLEY JAY TChief Executive OfficerApr 12Sale170.0520,0003,401,014488,061Apr 14 06:42 PM
WHITFIELD ROY ADirectorApr 12Sale170.004,000680,0001,800Apr 14 06:21 PM
WALT DAVID RDirectorApr 07Option Exercise13.304,00053,200635,840Apr 11 05:58 PM
WALT DAVID RDirectorApr 07Sale168.904,000675,596631,840Apr 11 05:58 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerApr 05Sale166.072,141355,54630,397Apr 06 05:29 PM
Dadswell CharlesSr VP & General CounselApr 04Sale167.818,3821,406,60449,859Apr 06 05:19 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerMar 23Sale155.052,141331,95732,538Mar 23 05:41 PM
FLATLEY JAY TChief Executive OfficerMar 22Option Exercise36.3010,000363,000498,061Mar 23 05:39 PM
FLATLEY JAY TChief Executive OfficerMar 22Sale154.1810,0001,541,759488,061Mar 23 05:39 PM
BRADBURY DANIELDirectorMar 21Option Exercise44.511,20053,41215,576Mar 22 02:51 PM
BRADBURY DANIELDirectorMar 21Sale155.631,200186,75614,376Mar 22 02:51 PM
Naclerio NicholasSr VP, Corporate DevelopmentMar 21Sale154.254,520697,21030,020Mar 22 02:48 PM
BOWMAN A BLAINEDirectorMar 17Option Exercise36.295,000181,45018,615Mar 18 08:49 PM
BOWMAN A BLAINEDirectorMar 17Sale145.245,000726,19213,615Mar 18 08:49 PM
WALT DAVID RDirectorMar 15Option Exercise13.304,00053,200635,840Mar 16 09:16 PM
WALT DAVID RDirectorMar 15Sale149.994,000599,961631,840Mar 16 09:16 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerMar 14Sale155.915,892918,61834,679Mar 15 07:42 PM
OSTADAN OMEADEVP Ops, Products, StrategyMar 09Sale150.32871130,92955,189Mar 11 11:43 AM
FLATLEY JAY TChief Executive OfficerMar 08Option Exercise36.3010,000363,000500,915Mar 09 06:45 PM
OSTADAN OMEADEVP Ops, Products, StrategyMar 08Sale156.094,516704,90256,060Mar 09 06:52 PM